Torii Pharmaceutical Co Ltd
TSE:4551

Watchlist Manager
Torii Pharmaceutical Co Ltd Logo
Torii Pharmaceutical Co Ltd
TSE:4551
Watchlist
Price: 4 570 JPY -0.44%
Market Cap: 131.6B JPY

Torii Pharmaceutical Co Ltd
Other Non-Cash Items

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Torii Pharmaceutical Co Ltd
Other Non-Cash Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Non-Cash Items CAGR 3Y CAGR 5Y CAGR 10Y
Torii Pharmaceutical Co Ltd
TSE:4551
Other Non-Cash Items
ÂĄ3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-35%
Takeda Pharmaceutical Co Ltd
TSE:4502
Other Non-Cash Items
ÂĄ381.8B
CAGR 3-Years
270%
CAGR 5-Years
20%
CAGR 10-Years
22%
Daiichi Sankyo Co Ltd
TSE:4568
Other Non-Cash Items
-ÂĄ46.1B
CAGR 3-Years
-239%
CAGR 5-Years
N/A
CAGR 10-Years
4%
Otsuka Holdings Co Ltd
TSE:4578
Other Non-Cash Items
ÂĄ80.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
27%
Chugai Pharmaceutical Co Ltd
TSE:4519
Other Non-Cash Items
ÂĄ100.6B
CAGR 3-Years
-9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Astellas Pharma Inc
TSE:4503
Other Non-Cash Items
ÂĄ253.2B
CAGR 3-Years
42%
CAGR 5-Years
N/A
CAGR 10-Years
24%

Torii Pharmaceutical Co Ltd
Glance View

Market Cap
128.5B JPY
Industry
Pharmaceuticals

Torii Pharmaceutical Co., Ltd. engages in the manufacturing and marketing of pharmaceutical products. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 560 full-time employees. The company went IPO on 2013-10-01. The Company’s main product categories include oral pruritus improving agents, proteolytic enzyme inhibitors, hyperkalemia improving agents, topical adrenocortical hormones, allergen immunotherapy for cedar pollinosis, allergen immunotherapy for mite allergy, active viable bacterial preparations, uterine contraction inhibitors in premature birth and others. The Company’s main products include Remitch, Riona tablets, Keixalate, Yulinome tablets, Antebate, Locoid, Zefnate, Sida Torengi pollen sublingual solution, Miticure mite sublingual tablet, Biosley, Magcent and others.

Intrinsic Value
4 709.68 JPY
Undervaluation 3%
Intrinsic Value
Price

See Also

What is Torii Pharmaceutical Co Ltd's Other Non-Cash Items?
Other Non-Cash Items
3m JPY

Based on the financial report for Dec 31, 2024, Torii Pharmaceutical Co Ltd's Other Non-Cash Items amounts to 3m JPY.

What is Torii Pharmaceutical Co Ltd's Other Non-Cash Items growth rate?
Other Non-Cash Items CAGR 10Y
-35%

Back to Top